Results 101 to 110 of about 30,750 (313)
Emerging Frontiers in Clinical Mycology: Innovations, Insights, and Impacts
ABSTRACT The Mycoses Study Group Education and Research Consortium (MSGERC)—a group comprising clinicians, researchers, patients, and industry partners—meets every 2 years to review the most significant challenges facing the clinical mycology community and plan research, education, and advocacy strategies to prevent fungal infections and improve ...
A. Apostolopoulou +7 more
wiley +1 more source
Treatment of candidemia caused by Candida albicans and Candida non - albicans in patients with hematological malignancies [PDF]
Aim. To study the risk factors, symptoms and outcomes of candidemia caused by C. albicans and C. non - albicans in patients with hematological malignancies. Materials and methods. The study included patients with hematological malignancies and candidemia.
G A Klyasova +6 more
doaj +1 more source
Quantitative Analysis of Candida Cell Wall Components by Flow Cytometrywith Triple-Fluorescence Staining [PDF]
This work was supported by the European Commission within the FP7 Framework Programme [Fungitect-Grant No 602125]. We also thank Thomas Sauer, Vienna Biocenter Campus (VBC), Austria, for technical support at the FACS facility of the MFPL, Karl Kuchler ...
Gow, N +5 more
core +1 more source
ABSTRACT Background Invasive fungal infections (IFI) are a prominent cause of morbidity and mortality among patients with haematological malignancies (HMs). Diagnostic work‐up excluding IFI is mandatory in case of persistent fever while antifungal treatment (AFT) is started.
Criscuolo Marianna +29 more
wiley +1 more source
A low serum uric acid concentration predicts a poor prognosis in adult patients with candidemia
This study aimed to determine the relation of serum uric acid (UA) level with outcomes in adults with candidemia. Medical records of patients with candidemia treated from 2014 to 2017 were retrospectively reviewed. Patients were age- and sex-matched with
Zhou Yuqi, Li Wenjuan, Huang Yubo
doaj +1 more source
Overcoming resistance of Candida albicans using photodynamic inactivation
The rising resistance of Candida albicans to conventional antifungals, like Amphotericin B (AmB), highlights the need for alternative treatments. This study evaluated the antifungal effectiveness of combining AmB with photodynamic inactivation (PDI) using curcumin as a photosensitizer.
Gabriela Gomes Guimarães +5 more
wiley +1 more source
Asymptomatic Candiduria due to Candida inconspicua in a Patient With Hematologic Malignancy
Candida inconspicua is an uncommon opportunistic yeast, increasingly reported in immunocompromised patients. We describe a case of asymptomatic Candiduria caused by C. inconspicua in a 43‐year‐old woman with Philadelphia chromosome‐positive B‐cell acute lymphoblastic leukemia undergoing chemotherapy.
Andrés Soto +12 more
wiley +1 more source
Candidemia in Finland, 1995–1999 [PDF]
We analyzed laboratory-based surveillance candidemia data from the National Infectious Disease Register in Finland and reviewed cases of candidemia from one tertiary-care hospital from 1995 to 1999. A total of 479 candidemia cases were reported to the Register. The annual incidence rose from 1.7 per 100,000 population in 1995 to 2.2 in 1999.
Eira Poikonen +3 more
openaire +3 more sources
Candida auris is an emerging multidrug‐resistant fungal pathogen that poses a serious global health threat. In our study, we comprehensively delineate both the pan‐genomic and transcriptomic features of C. auris. Intriguingly, our findings reveal an unexpected alkaline pH‐dependent regulation required for C. auris virulence and commensalism mediated by
Chaoyue Xu +30 more
wiley +1 more source
Candidemia is an important healthcare-associated infection (HAI) in intensive care units (ICUs). However, limited research has been conducted on candidemia in the Republic of Korea. We aimed to analyze the secular trends in the incidence and distribution
Eun Jin Kim +10 more
doaj +1 more source

